… the neuronal death in Alzheimer disease and possibly … cortical metabolism with nootropics.
Such pharmacological approaches do not attempt to slow the very rapid destruction of cortical …

… acid composition in brain samples from Alzheimer disease patients and agematched controls,
… formation in brain cortex by proteomic techniques. Alzheimer disease was associated with …

… the cause(s) of Alzheimer disease. Numerous mouse transgenic lines … human APP transgenes
result in the deposition of Aβ peptide, similar but not identical to the Aβ peptide of human …

… We previously reported human cortical proteins that are implicated in Alzheimer dementia. …
proteins for underlying disease mechanisms, we investigated cortical protein associations …

… This study demonstrated that the insular cortex is a prominent target of Alzheimer disease.
In many cases of Alzheimer disease, the insula is heavily burdened with NFTs, NPs, and Alz-…

We initiated the systematic profiling of the dorsolateral prefrontal cortex obtained from a
subset of autopsied individuals enrolled in the Religious Orders Study (ROS) or the Rush …

… of undetected disease. We review recent research on changes of the cerebral cortex and …
We argue that prominent cortical reductions are evident in fronto-temporal regions in elderly …

BACKGROUND: The aim of this study was to determine whether neocortical long-term
potentiation (LTP) is deficient in patients with Alzheimer’s disease (AD) and in amyloid precursor …

… increasing in a disease-dependent fashion. These correlations implicate an involvement of
oxidative stress in Alzheimer disease-related synaptic loss. Alzheimer disease, Free radicals, …

… Brains of Alzheimer’s disease (AD) patients are characterized in part by the formation of …
Here, we addressed the role of QC in AD pathogenesis in human cortex. Two sets of human …